$2.28T
Total marketcap
$351.69B
Total volume
BTC 55.11%     ETH 9.40%
Dominance

Antigenics ANTI Stock

$0.00   0.000000%
Add to favorites
Market Cap
$0.00
LOW - HIGH [24H]
$0.00 - $0.00
VOLUME [24H]
$3.00K
P/E Ratio
0
Earnings per share
$0.00
ISIN
US0370311013
Price   Prediction

Antigenics Price Chart

Sorry, that's all we've gotfor now...

Antigenics ANTI Financial and Trading Overview

Antigenics stock price 0.0000 USD
Previous Close 1.0E-5 USD
Open 7.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 7.0E-6 - 7.0E-6 USD
52 Week Range 7.0E-6 - 1.0E-5 USD
Volume 3K USD
Avg. Volume 0 USD
Market Cap N/A
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ANTI Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Antigenics Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 0%
S&P500 52-Week Change 27.29%
52 Week High 1.0E-5 USD
52 Week Low 7.0E-6 USD
50-Day Moving Average 1.0E-5 USD
200-Day Moving Average 1.0E-5 USD

ANTI Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding N/A
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq) N/A
Next Fiscal Year End N/A

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Antigenics

Country United States
State MA
City Lexington
Address 3 Forbes Road
ZIP 02421-7305
Phone 781 674 4400
Website https://agenusbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.

Q&A For Antigenics Stock

What is a current ANTI stock price?

Antigenics ANTI stock price today per share is 0.0000 USD.

How to purchase Antigenics stock?

You can buy ANTI shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Antigenics?

The stock symbol or ticker of Antigenics is ANTI.

Which industry does the Antigenics company belong to?

The Antigenics industry is Biotechnology.

How many shares does Antigenics have in circulation?

The max supply of Antigenics shares is 0.

What is Antigenics Price to Earnings Ratio (PE Ratio)?

Antigenics PE Ratio is now.

What was Antigenics earnings per share over the trailing 12 months (TTM)?

Antigenics EPS is 0 USD over the trailing 12 months.

Which sector does the Antigenics company belong to?

The Antigenics sector is Healthcare.

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap

Select currency